IMI—Interventions for Controlling Myopia Onset and Progression 2025
Investigative Ophthalmology & Visual Science · 17.09.2025 · 66 (12) · 39
DOI: 10.1167/iovs.66.12.39 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 17.09.2025. Verfasst von Mark A Bullimore und 26 weiteren Autor:innen. Beteiligte Einrichtung: College of Optometry, University of Houston, Houston, Texas, United States. Hauptthemen laut MEDLINE: Myopia, Refraction, Ocular, Myopia, Degenerative. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 425 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Myopia is recognized as a significant public health problem, particularly in East and Southeast Asia. This has led to the development and evaluation of a range of interventions to slow its progression and delay its onset. Since the publication of the 2019 International Myopia Institute's review of interventions for controlling myopia onset and progression, treatment options have continued to grow in number. This article reviews the efficacy of such interventions under five categories: optical, pharmacological, environmental (behavioral), colored light, and surgical. In summarizing the efficacy of mature technologies, only randomized controlled trials were considered, although such data are very limited for emerging treatments. The overall conclusion is that there are multiple effective interventions in most categories. Further research should aim to understand the mechanisms underlying myopia progression and the modalities that slow its progression in order to develop more effective treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Optometry, University of Houston, Houston, Texas, United States.
- Centre for Optometry and Vision Science, Ulster University, Northern Ireland, United Kingdom.
- National Centre for Optics, Vision and Eye Care, Faculty of Health and Social Sciences, University of South-Eastern Norway, Kongsberg, Norway.
- Department of Ophthalmology and Vision Science, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, People's Republic of China.
- NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, People's Republic of China.
- Shanghai Research Center of Ophthalmology and Optometry, Shanghai, People's Republic of China.
Zitieren
APA
Bullimore, M. A., Saunders, K. J., Baraas, R. C., Berntsen, D. A., Chen, Z., Chia, A. W. L., Goto, S., Jiang, J., Lan, W., Logan, N. S., Najjar, R. P., Polling, J. R., Read, S. A., Woodman-Pieterse, E. C., Széll, N., Verkicharla, P. K., Wu, P. C., Zhu, X., Loughman, J., …, & Wildsoet, C. F. (2025). IMI—Interventions for Controlling Myopia Onset and Progression 2025. Investigative Ophthalmology & Visual Science, 66(12), 39. https://doi.org/10.1167/iovs.66.12.39
Vancouver
Bullimore MA, Saunders KJ, Baraas RC, Berntsen DA, Chen Z, Chia AWL, et al. IMI—Interventions for Controlling Myopia Onset and Progression 2025. Investigative Ophthalmology & Visual Science. 2025;66(12):39. doi:10.1167/iovs.66.12.39
BibTeX
@article{Bullimore2025,
author = {Bullimore, Mark A and Saunders, Kathryn J and Baraas, Rigmor C and Berntsen, David A and Chen, Zhi and Chia, Audrey Wei Lin and Goto, So and Jiang, Jun and Lan, Weizhong and Logan, Nicola S and Najjar, Raymond P and Polling, Jan Roelof and Read, Scott A and Woodman-Pieterse, Emily C and Széll, Noémi and Verkicharla, Pavan K and Wu, Pei-Chang and Zhu, Xiaoying and Loughman, James and Nagra, Manbir and Phillips, John R and Tran, Huy D M and Vera-Diaz, Fuensanta A and Yam, Jason and Liu, Yue M and Singh, Sarah E and Wildsoet, Christine F},
title = {IMI—Interventions for Controlling Myopia Onset and Progression 2025},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {12},
pages = {39},
doi = {10.1167/iovs.66.12.39}
}
EUVIMED